Brief: MiMedx Group Says Robert Stein’s Position As President Of Regenerative Medicine Business Unit Eliminated, And He Will Be Departing From The Company
20/06/2023 21:56
June 20 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX GROUP INC- ROBERT STEIN’S POSITION AS PRESIDENT OF
REGENERATIVE MEDICINE BUSINESS UNIT ELIMINATED, AND HE WILL BE
DEPARTING FROM THE COMPANY
Further company coverage: MDXG.O
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates